Correction of previously issued consolidated financial statements (Tables)

9 Months Ended

Sep. 30, 2012

Correction of previously issued consolidated financial statements [Abstract]

Statement of Operations and Comprehensive Income (Loss) Information

	Three months ended September 30, 2011									Nine months ended September 30, 2011
	As previously reported			Corrections			As corrected			As previously reported			Corrections			As corrected
Research and development expenses		(793,702	)		(30,033	)		(823,735	)		(2,302,163	)					(2,302,163	)
Selling and distribution expenses		(1,487,490	)		(11,465	)		(1,498,955	)		(3,654,303	)					(3,654,303	)
General and administrative expenses, including stock-based compensation		(2,242,458	)		41,498			(2,200,960	)		(6,406,295	)					(6,406,295	)
Interest expense		(140,240	)		35,125			(105,115	)		(183,450	)		(181,807	)		(365,257	)
Loss before taxes		(739,318	)		35,125			(704,193	)		(345,865	)		(181,807	)		(527,672	)
Net loss		(665,635	)		35,125			(630,510	)		(414,960	)		(181,807	)		(596,767	)
Comprehensive loss		(603,836	)		35,125			(568,711	)		805,425			(181,807	)		623,618
Loss per share of common stock attributable to the Company
-Basic		(0.05	)					(0.05	)		(0.03	)		(0.01	)		(0.04	)
-Diluted		(0.05	)					(0.05	)		(0.03	)		(0.01	)		(0.04	)

Statement of Cash Flow Information

	Nine months ended September 30, 2011
	As previously reported			Corrections			As corrected
Cash flows from operating activities
Net (loss) income		(414,960	)		(181,807	)		(596,767	)
Net cash flows used in operating activities		(894,251	)		(181,807	)		(1,076,058	)
Cash flows from investing activities
Acquisition of plant and equipment		(5,168,156	)		181,807			(4,986,349	)
Net cash flows used in investing activities		(5,168,156	)		181,807			(4,986,349	)